Structural basis for the inhibition of coronaviral main proteases by PF-00835231.
The main protease (M pro) of coronaviruses plays a key role in viral replication, thus serving as a hot target for drug design. PF-00835231 is a promising inhibitor of SARS-CoV-2 M pro. Here, we report the inhibitory potency of PF-00835231 against SARS-CoV-2 M pro and seven M pro mutants (G15S, ... M49I, Y54C, K90R, P132H, S46F, and V186F) from SARS-CoV-2 variants. The results confirm that PF-00835231 has broad-spectrum inhibition against various coronaviral M pros. In addition, the crystal structures of SARS-CoV-2 M pro, SARS-CoV M pro, MERS-CoV M pro, and seven SARS-CoV-2 M pro mutants (G15S, M49I, Y54C, K90R, P132H, S46F, and V186F) in complex with PF-00835231 are solved. A detailed analysis of these structures reveals key determinants essential for inhibition and elucidates the binding modes of different coronaviral M pros. Given the importance of the main protease for the treatment of coronaviral infection, structural insights into M pro inhibition by PF-00835231 can accelerate the design of novel antivirals with broad-spectrum efficacy against different human coronaviruses.
Mesh Terms:
Coronavirus 3C Proteases, Coronavirus Protease Inhibitors, Crystallography, X-Ray, Indoles, Leucine, Mutation, Protein Domains, Pyrrolidinones, Structure-Activity Relationship
Coronavirus 3C Proteases, Coronavirus Protease Inhibitors, Crystallography, X-Ray, Indoles, Leucine, Mutation, Protein Domains, Pyrrolidinones, Structure-Activity Relationship
Acta Biochim Biophys Sin (Shanghai)
Date: Jul. 29, 2024
PubMed ID: 39076076
View in: Pubmed Google Scholar
Download Curated Data For This Publication
257397
Switch View:
- Interactions 3